These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11416712)
1. Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain. Bossolasco S; Nilsson A; de Milito A; Lazzarin A; Linde A; Cinque P; Chiodi F AIDS; 2001 Jun; 15(9):1109-13. PubMed ID: 11416712 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma. Bossolasco S; Cinque P; Ponzoni M; Vigano MG; Lazzarin A; Linde A; Falk KI J Neurovirol; 2002 Oct; 8(5):432-8. PubMed ID: 12402169 [TBL] [Abstract][Full Text] [Related]
3. Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue. Schroeder JR; Saah AJ; Ambinder RF; Martinez-Maza O; Crabb Breen E; Variakojis D; Margolick JB; Jacobson LP; Rowe DT; Hoover DR Clin Immunol; 1999 Dec; 93(3):239-44. PubMed ID: 10600334 [TBL] [Abstract][Full Text] [Related]
4. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma. Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas. Cingolani A; Gastaldi R; Fassone L; Pierconti F; Giancola ML; Martini M; De Luca A; Ammassari A; Mazzone C; Pescarmona E; Gaidano G; Larocca LM; Antinori A J Clin Oncol; 2000 Oct; 18(19):3325-30. PubMed ID: 11013271 [TBL] [Abstract][Full Text] [Related]
6. Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome--associated non-Hodgkin's lymphoma. Yawetz S; Cumberland WG; van der Meyden M; Martínez-Maza O Blood; 1995 Apr; 85(7):1843-9. PubMed ID: 7703491 [TBL] [Abstract][Full Text] [Related]
7. Elevated serum level of soluble CD23 precedes development of B-non-Hodgkin's lymphoma in SIV-infected Rhesus monkeys. Hannig H; Buske C; Mätz-Rensing K; Hunsmann G; Hiddemann W; Bodemer W Int J Cancer; 1998 Aug; 77(5):734-40. PubMed ID: 9688307 [TBL] [Abstract][Full Text] [Related]
8. Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin's lymphomas: evidence from a meta-analysis. Huang YS; Zhou X; Yang ZF; Lv ZT Ann Hematol; 2018 Aug; 97(8):1317-1325. PubMed ID: 29750316 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. De Luca A; Antinori A; Cingolani A; Larocca LM; Linzalone A; Ammassari A; Scerrati M; Roselli R; Tamburrini E; Ortona L Br J Haematol; 1995 Aug; 90(4):844-9. PubMed ID: 7669663 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Cinque P; Brytting M; Vago L; Castagna A; Parravicini C; Zanchetta N; D'Arminio Monforte A; Wahren B; Lazzarin A; Linde A Lancet; 1993 Aug; 342(8868):398-401. PubMed ID: 8101902 [TBL] [Abstract][Full Text] [Related]
11. B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Anthony IC; Crawford DH; Bell JE Brain; 2003 May; 126(Pt 5):1058-67. PubMed ID: 12690046 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. Kersten MJ; Klein MR; Holwerda AM; Miedema F; van Oers MH J Clin Invest; 1997 Apr; 99(7):1525-33. PubMed ID: 9119996 [TBL] [Abstract][Full Text] [Related]
13. Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. Cingolani A; De Luca A; Larocca LM; Ammassari A; Scerrati M; Antinori A; Ortona L J Natl Cancer Inst; 1998 Mar; 90(5):364-9. PubMed ID: 9498486 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr viral load in cerebrospinal fluid as a diagnostic marker of central nervous system involvement of AIDS-related lymphoma. Yanagisawa K; Tanuma J; Hagiwara S; Gatanaga H; Kikuchi Y; Oka S Intern Med; 2013; 52(9):955-9. PubMed ID: 23648713 [TBL] [Abstract][Full Text] [Related]
15. Soluble Fc epsilon RII/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: analysis by ELISA for soluble Fc epsilon RII/CD23. Yoshikawa T; Nanba T; Kato H; Hori K; Inamoto T; Kumagai S; Yodoi J Immunomethods; 1994 Feb; 4(1):65-71. PubMed ID: 8069529 [TBL] [Abstract][Full Text] [Related]
16. Detection of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus DNA in CSF from persons infected with HIV who had neurological disease. Brink NS; Sharvell Y; Howard MR; Fox JD; Harrison MJ; Miller RF J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):191-5. PubMed ID: 9703169 [TBL] [Abstract][Full Text] [Related]
17. The significance of Epstein-Barr virus detected in the cerebrospinal fluid of people with HIV infection. Wang J; Ozzard A; Nathan M; Atkins M; Nelson M; Gazzard B; Bower M HIV Med; 2007 Jul; 8(5):306-11. PubMed ID: 17561877 [TBL] [Abstract][Full Text] [Related]
18. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584 [TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphoma in four children infected with the human immunodeficiency virus. Association with Epstein-Barr Virus and treatment. Nadal D; Caduff R; Frey E; Hassam S; Zimmermann DR; Seigneurin JM; Plüss HJ; Seger RA Cancer; 1994 Jan; 73(1):224-30. PubMed ID: 8275430 [TBL] [Abstract][Full Text] [Related]
20. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women. Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]